Physician profile
Thad Bourque
NPI 1912093709
$7,503.07
in general payments reported to CMS, 2019-2025
39 companies · $1,320 in 2025
The $1,320 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $422 · 2021: $2,147 · 2022: $876 · 2023: $1,101 · 2024: $1,504 · 2025: $1,320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,790 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,789.61 |
| Education | $135.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,466.32 | 2021-2024 | |
| Astellas Pharma US INC | $925.10 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $641.32 | 2021-2025 | Provenge |
| Abbvie INC. | $629.45 | 2020-2025 | Lupron Depot, Botox |
| Pfizer INC. | $612.37 | 2019-2025 | |
| Janssen Biotech, INC. | $374.43 | 2019-2025 | Erleada, Akeega |
| Bioprotect Medical, INC. | $312.23 | 2024-2025 | Bioprotect Balloon Implant System |
| Ethicon US, LLC | $270.59 | 2021-2025 | Stratafix, Evarrest, Echelon; Endopath |
| Sumitomo Pharma America, INC. | $250.92 | 2023-2025 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $237.31 | 2020-2025 | Keytruda, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $226.61 | 2022-2024 | |
| Allergan, INC. | $205.06 | 2019-2022 | |
| Coloplast Corp | $174.15 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $165.18 | 2025 | Adstiladrin |
| Procept Biorobotics Corporation | $135.29 | 2023 | Aquabeam Robotic System |
Show all 38 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thad Bourque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.